These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14686965)

  • 1. The effect of acarbose on insulin resistance in obese hypertensive subjects with normal glucose tolerance: a randomized controlled study.
    Rachmani R; Bar-Dayan Y; Ronen Z; Levi Z; Slavachevsky I; Ravid M
    Diabetes Obes Metab; 2004 Jan; 6(1):63-8. PubMed ID: 14686965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin.
    Derosa G; Mereu R; D'Angelo A; Salvadeo SA; Ferrari I; Fogari E; Gravina A; Palumbo I; Maffioli P; Randazzo S; Cicero AF
    J Clin Pharm Ther; 2010 Oct; 35(5):565-79. PubMed ID: 20831680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance.
    Derosa G; Cicero AF; D'Angelo A; Ragonesi PD; Ciccarelli L; Fogari E; Salvadeo SA; Ferrari I; Gravina A; Fassi R; Fogari R
    Clin Drug Investig; 2006; 26(9):529-39. PubMed ID: 17163286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RETRACTED: Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study.
    Derosa G; Maffioli P; D'Angelo A; Fogari E; Bianchi L; Cicero AF
    J Diabetes Complications; 2011; 25(4):258-66. PubMed ID: 21367625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of acarbose on insulin sensitivity and proinsulin in overweight subjects with impaired glucose tolerance.
    Laube H; Linn T; Heyen P
    Exp Clin Endocrinol Diabetes; 1998; 106(3):231-3. PubMed ID: 9710365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
    Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patients.
    Fischer S; Patzak A; Rietzsch H; Schwanebeck U; Köhler C; Wildbrett J; Fuecker K; Temelkova-Kurktschiev T; Hanefeld M
    Diabetes Obes Metab; 2003 Jan; 5(1):38-44. PubMed ID: 12542723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy and safety of acarbose in the treatment of obese subjects with non-insulin-dependent diabetes mellitus.
    Coniff RF; Shapiro JA; Seaton TB
    Arch Intern Med; 1994 Nov; 154(21):2442-8. PubMed ID: 7979840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acarbose improves indirectly both insulin resistance and secretion in obese type 2 diabetic patients.
    Delgado H; Lehmann T; Bobbioni-Harsch E; Ybarra J; Golay A
    Diabetes Metab; 2002 Jun; 28(3):195-200. PubMed ID: 12149599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study.
    Hoffmann J; Spengler M
    Am J Med; 1997 Dec; 103(6):483-90. PubMed ID: 9428831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The investigation of the efficacy of insulin glargine on glycemic control when combined with either repaglinide or acarbose in obese Type 2 diabetic patients.
    Duran C; Tuncel E; Ersoy C; Ercan I; Selimoglu H; Kiyici S; Guclu M; Erturk E; Imamoglu S
    J Endocrinol Invest; 2009 Jan; 32(1):69-73. PubMed ID: 19337019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of exenatide and acarbose on intra-abdominal fat content in patients with obesity and type-2 diabetes: A randomized controlled trial.
    Shi L; Zhu J; Yang P; Tang X; Yu W; Pan C; Shen M; Zhu D; Cheng J; Ye X
    Obes Res Clin Pract; 2017; 11(5):607-615. PubMed ID: 28161303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of acarbose on insulin sensitivity in elderly patients with diabetes.
    Meneilly GS; Ryan EA; Radziuk J; Lau DC; Yale JF; Morais J; Chiasson JL; Rabasa-Lhoret R; Maheux P; Tessier D; Wolever T; Josse RG; Elahi D
    Diabetes Care; 2000 Aug; 23(8):1162-7. PubMed ID: 10937515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved glycemic control by acarbose therapy in hypertensive diabetic patients: effects on blood pressure and hormonal parameters.
    Rosenbaum P; Peres RB; Zanella MT; Ferreira SR
    Braz J Med Biol Res; 2002 Aug; 35(8):877-84. PubMed ID: 12185379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance.
    Chiasson JL; Josse RG; Leiter LA; Mihic M; Nathan DM; Palmason C; Cohen RM; Wolever TM
    Diabetes Care; 1996 Nov; 19(11):1190-3. PubMed ID: 8908378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of acarbose add-on therapy in the treatment of overweight patients with Type 2 diabetes inadequately controlled with metformin: a double-blind, placebo-controlled study.
    Halimi S; Le Berre MA; Grangé V
    Diabetes Res Clin Pract; 2000 Sep; 50(1):49-56. PubMed ID: 10936668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.
    Chiasson JL; Josse RG; Hunt JA; Palmason C; Rodger NW; Ross SA; Ryan EA; Tan MH; Wolever TM
    Ann Intern Med; 1994 Dec; 121(12):928-35. PubMed ID: 7734015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acarbose on weight maintenance after dietary weight loss in obese subjects.
    Hauner H; Petzinna D; Sommerauer B; Toplak H
    Diabetes Obes Metab; 2001 Dec; 3(6):423-7. PubMed ID: 11903414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients.
    Halpern A; Mancini MC; Suplicy H; Zanella MT; Repetto G; Gross J; Jadzinsky M; Barranco J; Aschner P; Ramirez L; Matos AG
    Diabetes Obes Metab; 2003 May; 5(3):180-8. PubMed ID: 12681025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acarbose treatment on markers of insulin sensitivity and systemic inflammation.
    Rudovich NN; Weickert MO; Pivovarova O; Bernigau W; Pfeiffer AF
    Diabetes Technol Ther; 2011 Jun; 13(6):615-23. PubMed ID: 21488802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.